Cargando...
Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach
Over the past decade, precision cancer medicine has driven major advances in the management of advanced solid tumours with the identification and targeting of putative driver aberrations transforming the clinical outcomes across multiple cancer types. Despite pivotal advances in the characterization...
Guardado en:
| Publicado en: | Clin Med Insights Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833160/ https://ncbi.nlm.nih.gov/pubmed/29511362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554918759079 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|